A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors-Reference-Cited by-同舟云学术

A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors

Published:2019-04-11 Issue: Volume: Page:
ISSN:1057-9249
Container-title:Psycho-Oncology
language:en
Short-container-title:Psycho‐Oncology

Author:

Kasting Monica L.¹^ORCID,Conley Claire C.²^ORCID,Hoogland Aasha I.²^ORCID,Scherr Courtney L.³^ORCID,Kim Jongphil⁴^ORCID,Thapa Ram⁴,Reblin Maija²^ORCID,Meade Cathy D.²,Lee M. Catherine⁵,Pal Tuya⁶^ORCID,Quinn Gwendolyn P.⁷⁸^ORCID,Vadaparampil Susan T.²^ORCID

Affiliation:

1. Department of Health and KinesiologyPurdue University West Lafayette Indiana

2. Department of Health Outcomes and BehaviorMoffitt Cancer Center Tampa Florida

3. Department of Communication StudiesNorthwestern University Evanston Illinois

4. Division of Biostatistics and BioinformaticsMoffitt Cancer Center Tampa Florida

5. Comprehensive Breast ProgramMoffitt Cancer Center Tampa Florida

6. Department of MedicineVanderbilt University Medical Center Nashville Tennessee

7. Department of Obstetrics and GynecologyNew York University New York New York

8. Perlumutter Cancer CenterNew York University New York New York

Publisher

Wiley

Subject

Psychiatry and Mental health,Oncology,Experimental and Cognitive Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pon.5059

Reference32 articles.

1. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2‐, BRCA1‐ and non‐BRCA1/2 families as compared to sporadic breast cancer cases;Brekelmans CT;Eur J Cancer,2007

2. NCCN Guidelines Insights: Genetic/Familial High‐Risk Assessment: Breast and Ovarian, Version 2.2017;Daly MB;J Natl Compr Canc Netw,2017

3. Association of risk‐reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality;Domchek SM;JAMA,2010

4. DalyM AxilbundJE BryantE et al.The NCCN Genetic/Familial High‐Risk Assessment: Breast and Ovarian Clinical Practice Guideline version 1.2009. Available athttp://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf. To view most recent and complete version of guideline towww.nccn.org.2009. Accessed April 22nd 2009.

5. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group;Rebbeck TR;J Clin Oncol,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up;JNCI Cancer Spectrum;2024-02-29

2. Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib;Clinical Breast Cancer;2023-07

3. Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management: a systematic review of patient impact and experience;Frontiers in Health Services;2023-05-31

4. Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow;Journal of Clinical Oncology;2023-05-20

5. Genetic Evaluation for Hereditary Cancer Syndromes Among African Americans: A Critical Review;The Oncologist;2022-03-05